Mechanism of NLRP3 inflammasome intervention for synovitis in knee osteoarthritis: A review of TCM intervention
- PMID: 37065495
- PMCID: PMC10090545
- DOI: 10.3389/fgene.2023.1159167
Mechanism of NLRP3 inflammasome intervention for synovitis in knee osteoarthritis: A review of TCM intervention
Abstract
Objective: This paper briefly reviews the structure and function of NLRP3 inflammasomes, signaling pathway, relationship with synovitis in KOA, and intervention of traditional Chinese medicine (TCM) in NLRP3 inflammasomes as a means to improve its therapeutic potential and clinical application. Method: Literatures about NLRP3 inflammasomes and synovitis in KOA were reviewed to analyze and discuss. Result: NLRP3 inflammasome can activate NF-κB mediated signal transduction, which in turn causes the expression of proinflammatory cytokines, initiates the innate immune response, and triggers synovitis in KOA. The TCM monomer/active ingredient, decoction, external ointment, and acupuncture regulating NLRP3 inflammasomes are helpful to alleviate synovitis in KOA. Conclusion: The NLRP3 inflammasome plays a significant role in the pathogenesis of synovitis in KOA, TCM intervention targeting the NLRP3 inflammasome can be a novel approach and therapeutic direction for the treatment of synovitis in KOA.
Keywords: NLRP3 inflammasome; knee osteoarthritis; review; synovitis; traditional Chinese medicine.
Copyright © 2023 Han, Lin, Huang, Li, Li and Xie.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Chrysin Attenuates the NLRP3 Inflammasome Cascade to Reduce Synovitis and Pain in KOA Rats.Drug Des Devel Ther. 2020 Jul 28;14:3015-3027. doi: 10.2147/DDDT.S261216. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32801641 Free PMC article.
-
Agnuside Alleviates Synovitis and Fibrosis in Knee Osteoarthritis through the Inhibition of HIF-1α and NLRP3 Inflammasome.Mediators Inflamm. 2021 Mar 16;2021:5534614. doi: 10.1155/2021/5534614. eCollection 2021. Mediators Inflamm. 2021. PMID: 33814979 Free PMC article.
-
Vanillic Acid Reduces Pain-Related Behavior in Knee Osteoarthritis Rats Through the Inhibition of NLRP3 Inflammasome-Related Synovitis.Front Pharmacol. 2021 Feb 15;11:599022. doi: 10.3389/fphar.2020.599022. eCollection 2020. Front Pharmacol. 2021. PMID: 33658936 Free PMC article.
-
Pivotal regulatory roles of traditional Chinese medicine in ischemic stroke via inhibition of NLRP3 inflammasome.J Ethnopharmacol. 2022 Aug 10;294:115316. doi: 10.1016/j.jep.2022.115316. Epub 2022 May 2. J Ethnopharmacol. 2022. PMID: 35513214 Review.
-
A narrative review of positive regulation of NLRP3 inflammasome in rheumatoid arthritis.Ann Palliat Med. 2021 Dec;10(12):12877-12885. doi: 10.21037/apm-21-3472. Ann Palliat Med. 2021. PMID: 35016462 Review.
Cited by
-
Evidence supported by Mendelian randomization: impact on inflammatory factors in knee osteoarthritis.Front Med (Lausanne). 2024 May 28;11:1382836. doi: 10.3389/fmed.2024.1382836. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38863887 Free PMC article.
-
Targeting the NLRP3 inflammasome as a novel therapeutic target for osteoarthritis.Inflammopharmacology. 2025 Feb;33(2):461-484. doi: 10.1007/s10787-024-01629-2. Epub 2025 Jan 13. Inflammopharmacology. 2025. PMID: 39806051 Review.
-
Signal Transduction Pathways Involved in Acupuncture-Mediated Inhibition of Synovitis in Knee Osteoarthritis: A Comprehensive Review.Int J Gen Med. 2025 Jul 29;18:4105-4117. doi: 10.2147/IJGM.S528486. eCollection 2025. Int J Gen Med. 2025. PMID: 40756966 Free PMC article. Review.
-
From inflammation to immune regulation: The dual nature of dietary lectins in health and disease.Heliyon. 2024 Oct 18;10(20):e39471. doi: 10.1016/j.heliyon.2024.e39471. eCollection 2024 Oct 30. Heliyon. 2024. PMID: 39502251 Free PMC article. Review.
-
Suppressive effect of curcumin on apoptosis of articular chondrocytes via regulation on NF-κB pathway and NLRP3 inflammasome.Cytotechnology. 2025 Apr;77(2):52. doi: 10.1007/s10616-024-00695-2. Epub 2025 Jan 31. Cytotechnology. 2025. PMID: 39897107
References
Publication types
LinkOut - more resources
Full Text Sources